Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kipling

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Human Molecular Genetics|May 20, 2004
Normal telomere erosion rates at the single cell level in Werner syndrome fibroblast cellsDuncan M Baird, Terence Davis, Jan Rowson, et al.
Experimental Cell Research|January 15, 2004
Direct evidence from siRNA-directed "knock down" that p16(INK4a) is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferationJane Bond, Christopher Jones, Michele Haughton, et al.
Future Medicinal Chemistry|March 24, 2011
Synthesis of the highly selective p38 MAPK inhibitor UR-13756 for possible therapeutic use in Werner syndromeMark C Bagley, Terence Davis, Michal J Rokicki, et al.
Bioorganic & Medicinal Chemistry Letters|July 31, 2007
Rapid synthesis of VX-745: p38 MAP kinase inhibition in Werner syndrome cellsMark C Bagley, Terence Davis, Matthew C Dix, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Evaluating the role of p38 MAP kinase in growth of Werner syndrome fibroblastsTerence Davis, Marcus A Bachler, Fiona S Wyllie, et al.
Annals of the New York Academy of Sciences|April 27, 2007
The role of cellular senescence in Werner syndrome: toward therapeutic intervention in human premature agingTerence Davis, Fiona S Wyllie, Michal J Rokicki, et al.
Organic & Biomolecular Chemistry|February 23, 2007
Microwave-assisted synthesis of N-pyrazole ureas and the p38alpha inhibitor BIRB 796 for study into accelerated cell ageingMark C Bagley, Terence Davis, Matthew C Dix, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 13, 2005
Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitorTerence Davis, Duncan M Baird, Michèle F Haughton, et al.
Experimental Gerontology|January 25, 2005
Replicative senescence in sheep fibroblasts is a p53 dependent processTerence Davis, Julia W Skinner, Richard G A Faragher, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Use of p38 MAPK Inhibitors for the Treatment of Werner SyndromeMark C Bagley, Terence Davis, Paola G S Murziani, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Human Molecular Genetics|May 20, 2004
Normal telomere erosion rates at the single cell level in Werner syndrome fibroblast cellsDuncan M Baird, Terence Davis, Jan Rowson, et al.
Experimental Cell Research|January 15, 2004
Direct evidence from siRNA-directed "knock down" that p16(INK4a) is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferationJane Bond, Christopher Jones, Michele Haughton, et al.
Future Medicinal Chemistry|March 24, 2011
Synthesis of the highly selective p38 MAPK inhibitor UR-13756 for possible therapeutic use in Werner syndromeMark C Bagley, Terence Davis, Michal J Rokicki, et al.
Bioorganic & Medicinal Chemistry Letters|July 31, 2007
Rapid synthesis of VX-745: p38 MAP kinase inhibition in Werner syndrome cellsMark C Bagley, Terence Davis, Matthew C Dix, et al.
Annals of the New York Academy of Sciences|June 12, 2010
Evaluating the role of p38 MAP kinase in growth of Werner syndrome fibroblastsTerence Davis, Marcus A Bachler, Fiona S Wyllie, et al.
Annals of the New York Academy of Sciences|April 27, 2007
The role of cellular senescence in Werner syndrome: toward therapeutic intervention in human premature agingTerence Davis, Fiona S Wyllie, Michal J Rokicki, et al.
Organic & Biomolecular Chemistry|February 23, 2007
Microwave-assisted synthesis of N-pyrazole ureas and the p38alpha inhibitor BIRB 796 for study into accelerated cell ageingMark C Bagley, Terence Davis, Matthew C Dix, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 13, 2005
Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitorTerence Davis, Duncan M Baird, Michèle F Haughton, et al.
Experimental Gerontology|January 25, 2005
Replicative senescence in sheep fibroblasts is a p53 dependent processTerence Davis, Julia W Skinner, Richard G A Faragher, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Use of p38 MAPK Inhibitors for the Treatment of Werner SyndromeMark C Bagley, Terence Davis, Paola G S Murziani, et al.
Pageof 9